Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- When There Is Blood In The Streets - Buy Biotech
Oct 10, 2008 07:37 PM
- Exelixis as a Platform Company
Sep 03, 2008 01:34 AM
- Genentech’s Shiny New Platform
Aug 06, 2008 04:33 AM
- Immunogen at ASCO Annual Meeting 2008
Jul 15, 2008 08:41 AM
- Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma and Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer
Jun 05, 2008 09:59 AM
- Published Third Party, Independent Research Corroborates Promise of TAP Cancer Therapeutic as a Therapy for the Treatment of Cancer and American Oriental Bioengineering Announces US$75 Million Share Repurchase Program
Jun 02, 2008 02:29 PM
- Immunogen and Seattle Genetics – On The Verge Of An Inflection Point
May 24, 2008 12:35 PM
- Seattle Genetics 1Q Loss Widens On R&D, Revenue Jumps
Apr 24, 2008 05:07 PM
- Micromet - Biting Cancer (Part I)
Jan 29, 2008 01:25 PM
- Big Blue
Jan 14, 2008 10:13 AM
- Seattle Genetics to Present at the Oppenheimer Healthcare Conference
Oct 29, 2008 09:20 AM
- Seattle Genetics Presents Preclinical Data on Antibody-Drug Conjugate Programs
Oct 24, 2008 09:04 AM
- Seattle Genetics Reports Development Progress and Third Quarter 2008 Financial Results
Oct 23, 2008 04:21 PM
- Seattle Genetics to Host Conference Call and Webcast Discussion of Third Quarter 2008 Financial Results on October 23, 2008
Oct 16, 2008 09:08 AM
- Seattle Genetics Achieves Milestone Under Antibody-Drug Conjugate Collaboration with Progenics
Oct 15, 2008 09:15 AM
- Seattle Genetics Adds to Senior Management Team
Sep 30, 2008 09:09 AM
- Seattle Genetics to Present at the UBS Global Life Sciences Conference
Sep 17, 2008 09:01 AM
- Seattle Genetics to Present at Upcoming Investor Conferences
Aug 27, 2008 09:10 AM
- Seattle Genetics Initiates SGN-70 Phase I Clinical Trial
Jul 31, 2008 11:18 AM
- Seattle Genetics Reports Second Quarter 2008 Financial Results
Jul 22, 2008 04:19 PM
- Form 4 DOBMEIER ERIC For: Sep 26 (10K)
Sep 30, 2008 08:08 PM
- Form 4 SEATTLE GENETICS INC For: Sep 22 Filed by: Reynolds Thomas C (10K)
Sep 24, 2008 08:13 PM
- Form 4/A SEATTLE GENETICS INC For: Sep 19 Filed by: AKKARAJU SRINIVAS (10K)
Sep 24, 2008 05:00 PM
- Form 4/A SEATTLE GENETICS INC For: Sep 18 Filed by: AKKARAJU SRINIVAS (10K)
Sep 24, 2008 03:12 PM
- Form 4 SEATTLE GENETICS INC For: Sep 22 Filed by: AKKARAJU SRINIVAS (10K)
Sep 23, 2008 06:04 PM
- Form 4 SEATTLE GENETICS INC For: Sep 19 Filed by: AKKARAJU SRINIVAS (10K)
Sep 22, 2008 04:51 PM
- Form 4 SEATTLE GENETICS INC For: Sep 18 Filed by: AKKARAJU SRINIVAS (10K)
Sep 19, 2008 03:48 PM
- Form 4 DOBMEIER ERIC For: Sep 16 (10K)
Sep 18, 2008 07:27 PM
- Form 4 SIMPSON TODD E For: Aug 27 (10K)
Aug 29, 2008 05:26 PM
- Form 4 SIEGALL CLAY B For: Aug 27 (10K)
Aug 29, 2008 05:26 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
SGEN
|
Compare to S&P
|
| YTD |
-17.72 %
|
46.90 %
|
| 4 Weeks |
5.75 %
|
17.58 %
|
| 12 Weeks |
-15.42 %
|
34.40 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -35.00 %
|
|
EPS Growth in Last Year: -0.01 %
|
|
Sales Growth in Last Quarter: -19.24 %
|
|
Sales Growth in Last Quarter: 74.49 %
|
|
|
